I have been trying to post a blog for over a week now. My browser kept kicking me off when I would try and create a new post, so I finely conceded to use IE (I normally use Mozilla), and I can finally post! We had such a great, relaxing time in Maui. It seems like we’ve been home for months, already, but yet I can’t believe I’m leaving this weekend, already, for Oklahoma.
I’m going to go ahead and paste an email that was sent to us by the clinic, explaining the treatment that we will be receiving. A lot of you have been asking for specific information about what we’re doing exactly, so here it is:
For the first four days they are given formula A, which consists of high dose vitamin C+B17 (formerly known as Laetrile) in combination with a full dosage of DMSO, to carry it into the malignancy better. Then on day 5, they are switched off to formula B, which consists of sodium bicarbonate in D5W. The patient usually has a Herxheiber reaction during this time, which is your hard evidence that the treatment is hitting the target. At the end of the 8 days on formula B, we switch the patient off onto formula C, which consists of DMSO bound with sterile dextrose, which acts as the “bait” for any malignancy which might be remaining. They finish out their round of 20 treatments on the DMSO/dextrose formula.
We have been successfully treating prostate cancer, as well asglioblastoma multiforme and astrocytoma, for over ten years and counting. Although DMSO is our primary chemotherapy agent(natural, non-toxic, yet powerfully effective) we also have incorporated Dr.Simoncini’s Sodium Bicarbonate, as well. DMSO,being highly alkaline and fungicidal, is a potent cancer killer by itself, as well as being a great carrier solvent, which will bind with and deliver anything of a similar molecular structure. Thousands of patients have received it, going back over 30 years, in many published clinical trials. Yet you will never hear about it, because it is a natural, botanically derived substance which is unpatentable, and therefore in direct competition with costly chemotherapy chemicals which are the standard of mainstream medicine. Despite all the evidence for efficacy of DMSO as an effective nontoxic chemotherapy agent, the FDAhas never approved it for that purpose. Because of DMSO’s special properties as a carrier solvent, it can bind with any other substance of a similar molecular structure and carry it across the cell membrane, right into the tumor. When it is given intravenously, it crosses out of the circulation and totally saturates the soft tissues and even penetrates the blood/brain barrier, which is why it is so effective against brain malignancies. It will gently and painlessly eradicate a brain tumor without causing any collateral damage to nearby healthy structures, unlike surgery. And because it can also penetrate deep into the bone marrow, it is effective against myeloma and late stage prostate cancer, which typically goes into the deep pelvic bones.